Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 12/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6229619 | 0.87 | NR4A2 (0.58) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6207458 | 0.85 | PPARD (0.49) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539618 | 0.84 | PPARD (0.48) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539225 | 0.83 | PPARD (0.49) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539702 | 0.83 | PPARD (0.49) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539723 | 0.82 | PPARD (0.47) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539519 | 0.82 | PPARD (0.47) | PPARDFAAHALDH1A1LMNAHTT | |
| SCHEMBL6235969 | 0.82 | PPARD (0.47) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539638 | 0.82 | PPARD (0.47) | PPARDALDH1A1LMNAHTTNPSR1 | |
| SCHEMBL6539351 | 0.82 | RAB9A (0.53) | PPARDALDH1A1LMNAHTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157891-A1 | Inhibitor of cox | PTGS1, PTGS2, PTGES2 | PPARD 1747/4885FAAH 96/4885ALDH1A1 163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.